PhoreMost
Cambridge, Massachusetts, United States · Biopharma, Biotechnology, Pharmaceutical · 32 employees
PhoreMost is a biopharmaceutical company specializing in the development of next-generation drug targets through its innovative SITESEEKER platform. The company focuses on degrader programs, particularly in oncology and inflammatory diseases. With recent funding, it aims to advance its pipeline of novel degrader assets toward preclinical development. PhoreMost is committed to revolutionizing medic
Funding history
- Series series b — $9.0M — Sep 2024
Recent signals
- Jun 10, 2026: PhoreMost Appoints Gabriel Fox as Chief Medical Officer
- Sep 10, 2024: Raised $9.0M in Series series b
See plans & pricing → Track PhoreMost’s funding, hiring, and signals — with verified contacts — on Fundz.